Stock info Rhoen-Klinikum | Filter  Basic-Info

Rh�n-Klinikum

The past year was a profitable year Rh�n-Klinikum investors

The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 7 percent. Over the past 5 years Rh�n-Klinikum' stock rose at around 79 percent in value. Rh�n-Klinikum's revenues between 2011 and 2015 were quite unstable and moved between 2,86 billion euros and 1,11 billion euros. Rh�n-Klinikum's net results between 2011 and 2015 were quite unstable and moved between 161,07 million euros and 87,44 million euros.

Rh�n-Klinikum is active in the support services sector. The past 10 years the (international) industry gained at around 20 percent. Measured since 2011 the sector is 17 percent higher and over the past 12 months (December 2015-2016) there is a minus of 20 percent.

The German company paid out dividends in the past 5 years. On average Rh�n-Klinikum's dividend yield over the past 5 years was around 2,55 percent annually. Over the period 2011-2015 Rh�n-Klinikum raised it's dividends per share each year. So we could call Rh�n-Klinikum a kind of dividend aristocrat.

Rh�n-Klinikum financed with relatively low debt

At the end of 2015 the support company's balance sheet was worth 1,63 billion euros. Last year the total debt of the company was 546,53 million euros. This equals around 33,44 percent of the total balance sheet. As per the end of 2015 Rh�n-Klinikum's price/earnings-ratio equaled 19. So investors paid for 1 stock 19 times the earnings per share of 2015. Based on it's price/earnings-ratio and dividend yield the German stock can be seen as a value stock.

At the end of 2015 the German company's market capitalization equaled around 1,94 billion euros. At the end of 2015 around 72,05 million stocks were listed.

All the company's financial reports are available here. More information about Rh�n-Klinikum can be found it's website. .